%0
Generic
%T
Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.
%A Stock, Wendy
%A Harvey, Richard
%A Moser, Barry
%A Sher, Dorie
%A Schachter-Tokarz, Esther
%A Myers, Matthew
%A Slack, James
%A Powell, Bayard
%A Bloomfield, Clara D.
%A Larson, Richard A.
%A Tallman, Martin S.
%A Appelbaum, Frederick R.
%A Feusner, James
%A Willman, Cheryl
%A Gallagher, Robert
%I American Society of Hematology
%@ 0006-4971
%@ 1528-0020
%K Cell Biology
%K Hematology
%K Immunology
%K Biochemistry
%D 2006
%C American Society of Hematology
%U http://slubdd.de/katalog?TN_libero_mab2